Here we have comprehensively examined ETS1 in HNSCC, where we find ETS1 to be specifically enriched in expression across cell lines, human tumors and PDXs representing the mesenchymal subtype and associated with poor tumor outcome. This evidence concerns the gene ETS1 and neoplasm.